Third-Party Payers v. Eli Lilly & Co. In re: Zyprexa
September 5, 2008 This page provides links to all three sections of the nearly 300-page decision to grant class action status to a lawsuit filed by third-party payers against Eli Lilly and Company for overcharging for Zyprexa, an antipsychotic medication. The plaintiffs include pension funds, labor unions, and insurance companies. The plaintiffs say Lilly overcharged, hid side effects such as weight gain and diabetes, and encouraged physicians to use the medication for conditions not approved by the U.S. Food and Drug Administration (FDA). In addition, the plaintiffs claim that Lilly violated the Racketeer Influenced and Corrupt Organizations . . .
